semaglutide weight loss tracker results week by week: timeline from first dose to full results The Injectable Weight Loss Medicine

GLP-1 receptor agonists emerged from diabetes research and now represent a major advancement in weight management

Current annual therapy cost: ~1.51.7 lakh per patient At 5060% lower pricing: ~70,00085,000 per year Savings of nearly 80,0001,00,000 per patient annually Now consider scale: 100,000 patients 75,000 750 crore annual market 500,000 patients (just ~0.5% of high-risk obese population) 3,750 crore opportunity And thats only drug revenue

Once opened, compounded semaglutide typically lasts 28 days in the fridge

Videos and brochures are ready to download, order or share with your patients, with many available in Spanish.

We feel you

Despite new weight-loss drugs such as Saxenda, medication still isnt the answer to most peoples weight problems.